610 related articles for article (PubMed ID: 28383341)
1. Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors.
Hwang Y; Broxmeyer HE; Lee MR
Curr Opin Hematol; 2017 Jul; 24(4):283-288. PubMed ID: 28383341
[TBL] [Abstract][Full Text] [Related]
2. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.
Song B; Fan Y; He W; Zhu D; Niu X; Wang D; Ou Z; Luo M; Sun X
Stem Cells Dev; 2015 May; 24(9):1053-65. PubMed ID: 25517294
[TBL] [Abstract][Full Text] [Related]
3. Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term programming.
Izawa K; Yamazaki S; Becker HJ; Bhadury J; Kakegawa T; Sakaguchi M; Tojo A
Exp Hematol; 2020 Sep; 89():68-79.e7. PubMed ID: 32795499
[TBL] [Abstract][Full Text] [Related]
4. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.
Ou Z; Niu X; He W; Chen Y; Song B; Xian Y; Fan D; Tang D; Sun X
Sci Rep; 2016 Sep; 6():32463. PubMed ID: 27581487
[TBL] [Abstract][Full Text] [Related]
5. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
[TBL] [Abstract][Full Text] [Related]
7. Engineered Murine HSCs Reconstitute Multi-lineage Hematopoiesis and Adaptive Immunity.
Lu YF; Cahan P; Ross S; Sahalie J; Sousa PM; Hadland BK; Cai W; Serrao E; Engelman AN; Bernstein ID; Daley GQ
Cell Rep; 2016 Dec; 17(12):3178-3192. PubMed ID: 28009288
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 system and its applications in human hematopoietic cells.
Hu X
Blood Cells Mol Dis; 2016 Nov; 62():6-12. PubMed ID: 27736664
[TBL] [Abstract][Full Text] [Related]
9. One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system.
Wattanapanitch M; Damkham N; Potirat P; Trakarnsanga K; Janan M; U-Pratya Y; Kheolamai P; Klincumhom N; Issaragrisil S
Stem Cell Res Ther; 2018 Feb; 9(1):46. PubMed ID: 29482624
[TBL] [Abstract][Full Text] [Related]
10. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.
Ye L; Muench MO; Fusaki N; Beyer AI; Wang J; Qi Z; Yu J; Kan YW
Stem Cells Transl Med; 2013 Aug; 2(8):558-66. PubMed ID: 23847002
[TBL] [Abstract][Full Text] [Related]
11. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
12. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.
Ran D; Shia WJ; Lo MC; Fan JB; Knorr DA; Ferrell PI; Ye Z; Yan M; Cheng L; Kaufman DS; Zhang DE
Blood; 2013 Apr; 121(15):2882-90. PubMed ID: 23372166
[TBL] [Abstract][Full Text] [Related]
13. GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.
Jung M; Cordes S; Zou J; Yu SJ; Guitart X; Hong SG; Dang V; Kang E; Donaires FS; Hassan SA; Albitar M; Hsu AP; Holland SM; Hickstein DD; Townsley D; Dunbar CE; Winkler T
Blood Adv; 2018 Dec; 2(23):3553-3565. PubMed ID: 30538114
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
Dannenmann B; Nasri M; Welte K; Skokowa J
Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cells from induced pluripotent stem cells - considering the role of microRNA as a cell differentiation regulator.
Ferreira AF; Calin GA; Picanço-Castro V; Kashima S; Covas DT; de Castro FA
J Cell Sci; 2018 Feb; 131(4):. PubMed ID: 29467236
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity.
Nishizawa M; Chonabayashi K; Nomura M; Tanaka A; Nakamura M; Inagaki A; Nishikawa M; Takei I; Oishi A; Tanabe K; Ohnuki M; Yokota H; Koyanagi-Aoi M; Okita K; Watanabe A; Takaori-Kondo A; Yamanaka S; Yoshida Y
Cell Stem Cell; 2016 Sep; 19(3):341-54. PubMed ID: 27476965
[TBL] [Abstract][Full Text] [Related]
17. In vitro generation of HSC-like cells from murine ESCs/iPSCs by enforced expression of LIM-homeobox transcription factor Lhx2.
Kitajima K; Minehata K; Sakimura K; Nakano T; Hara T
Blood; 2011 Apr; 117(14):3748-58. PubMed ID: 21343610
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells.
Lim WF; Inoue-Yokoo T; Tan KS; Lai MI; Sugiyama D
Stem Cell Res Ther; 2013 Jun; 4(3):71. PubMed ID: 23796405
[TBL] [Abstract][Full Text] [Related]
19. Derivation of Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells.
Sugimura R
Methods Mol Biol; 2019; 2005():37-41. PubMed ID: 31175644
[TBL] [Abstract][Full Text] [Related]
20. Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells.
Kambal A; Mitchell G; Cary W; Gruenloh W; Jung Y; Kalomoiris S; Nacey C; McGee J; Lindsey M; Fury B; Bauer G; Nolta JA; Anderson JS
Mol Ther; 2011 Mar; 19(3):584-93. PubMed ID: 21119622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
